1AI 16.7% 0.7¢ algorae pharmaceuticals limited

100 percent insulin remission , page-5

  1. 71 Posts.
    Be aware that LCT's primary focus is type 1 diabetes rather than type 2 which is the one that results from lack of exercise and eating high energy foods. Type 1 (or Juvenile diabetes) is the 4th largest cause of death in the western world and currently directly costs Australia $100mill per year. Indirect costs include the longer term results of heart disease, greatest cause of blindness, amputation and suicide. This, in no way diminishes the amazing news they released today. Check out their website for more details.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $11.81M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $1.529K 244.8K

Buyers (Bids)

No. Vol. Price($)
4 179444 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1964350 8
View Market Depth
Last trade - 14.16pm 31/10/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.